Skip to main content

Table 1 Patient tumor and characteristics

From: Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease

  IBD No IBD p value
n % n %
Age      
 < 60 years 4 13% 860 20% 0.58
 60–70 years 15 48% 1840 44%  
 > 70 years 12 39% 1514 36%  
ECOG      
 0 18 58%    
 1 2 7%    
 No score 11 35%    
PSA (mg/mL)      
 < 10 24 77% 3281 78% 0.09
 10–20 3 10% 725 17%  
 > 20 4 13% 208 5%  
AJCC 8-edition stage      
 T1 24 77% 3436 82% 0.65
 T2 7 23% 733 17%  
 T3–T4 0 0% 45 1%  
Grade group      
 1 9 29% 1314 31% 0.83
 2 13 42% 1436 34%  
 3 4 13% 833 20%  
 4 3 10% 418 10%  
 5 2 6% 213 5%  
Risk group      
 Low 8 26% 1066 25% 0.97
 Intermediate 17 55% 2392 57%  
 High 6 19% 756 18%  
ADT      
 Yes 7 23% 943 22% 0.98
 No 24 77% 3271 78%  
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us